Trust Size
$95M
Current Price
$0.00
Peak Market Cap
$1.6B
Price Journey
What Happened
Pear Therapeutics was a pioneer in prescription digital therapeutics (PDTs), developing FDA-authorized software-based treatments for substance use disorders, insomnia, and other conditions. The company went public via SPAC merger with Thimble Point Acquisition Corp in 2021. It filed for Chapter 11 bankruptcy in April 2023.
Thimble Point Acquisition Corp merged with Pear Therapeutics in December 2021 at a $1.6 billion valuation. Despite having three FDA-authorized digital therapeutics products, Pear struggled with insurance reimbursement and physician adoption. The company burned through cash and filed for Chapter 11 in April 2023, just 16 months after going public. Its assets were sold for approximately $6 million.
Timeline
2021-01-26
S-1 Registration Filed
2023-05-02
Last SEC Filing
2023-04-07
Filed for bankruptcy
SEC Filing Details
CIK Number
1835567
Total SEC Filings
219
State of Incorporation
DE
Last Filing Date
2023-05-02
Business Location
New Haven, CT
Trust/Asset Size
$95M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for Pear Therapeutics